<?xml version="1.0" encoding="UTF-8"?>

<ValueSet xmlns="http://hl7.org/fhir">
  <id value="adverse-event-clinical-research-grades"/>
  <meta>
    <profile value="http://hl7.org/fhir/StructureDefinition/shareablevalueset"/>
  </meta>
  <text>
    <status value="generated"/><div xmlns="http://www.w3.org/1999/xhtml"><ul><li>Include these codes as defined in <a href="CodeSystem-v3-nciThesaurus.html"><code>http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl</code></a><table class="none"><tr><td style="white-space:nowrap"><b>Code</b></td><td><b>Display</b></td></tr><tr><td>C41338</td><td>Grade 1 Mild Adverse Event</td></tr><tr><td>C41339</td><td>Grade 2 Moderate Adverse Event</td></tr><tr><td>C41340</td><td>Grade 3 Severe Adverse Event</td></tr><tr><td>C41337</td><td>Grade 4 Life Threatening or Disabling Adverse Event</td></tr><tr><td>C48275</td><td>Grade 5 Death Related to Adverse Event</td></tr></table></li></ul></div>
  </text>
  <extension url="http://hl7.org/fhir/StructureDefinition/structuredefinition-wg">
    <valueCode value="brr"/>
  </extension>
  <extension url="http://hl7.org/fhir/StructureDefinition/structuredefinition-fmm">
    <valueInteger value="1"/>
  </extension>
  <url value="http://terminology.hl7.org/ValueSet/adverse-event-clinical-research-grades"/>
  <identifier>
    <system value="urn:ietf:rfc:3986"/>
    <value value="urn:oid:2.16.840.1.113883.11.21027"/>
  </identifier>
  <version value="0.1.0"/>
  <name value="AdverseEventClinicalResearchGrades"/>
  <title value="Adverse Event Clinical Research Grades"/>
  <status value="active"/>
  <experimental value="false"/>
  <date value="2023-07-28T19:27:19+00:00"/>
  <publisher value="SatuSehat"/>
  <contact>
    <name value="SatuSehat"/>
    <telecom>
      <system value="url"/>
      <value value="https://satusehat.kemkes.go.id/"/>
    </telecom>
    <telecom>
      <system value="email"/>
      <value value="fhir@dto.kemkes.go.id"/>
    </telecom>
  </contact>
  <description value="Value set of grades used in Adverse Event Clinical Research, especially in Oncology clinical trials"/>
  <copyright value="This material derives from the HL7 Terminology THO. THO is copyright Â©1989+ Health Level Seven International and is made available under the CC0 designation. For more licensing information see: https://terminology.hl7.org/license"/>
  <compose>
    <include>
      <system value="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl"/>
      <concept>
        <code value="C41338"/>
        <display value="Grade 1 Mild Adverse Event"/>
      </concept>
      <concept>
        <code value="C41339"/>
        <display value="Grade 2 Moderate Adverse Event"/>
      </concept>
      <concept>
        <code value="C41340"/>
        <display value="Grade 3 Severe Adverse Event"/>
      </concept>
      <concept>
        <code value="C41337"/>
        <display value="Grade 4 Life Threatening or Disabling Adverse Event"/>
      </concept>
      <concept>
        <code value="C48275"/>
        <display value="Grade 5 Death Related to Adverse Event"/>
      </concept>
    </include>
  </compose>
</ValueSet>